183 related articles for article (PubMed ID: 11550792)
1. Modulation of RNA function by oligonucleotides recognizing RNA structure.
Toulmé JJ; Di Primo C; Moreau S
Prog Nucleic Acid Res Mol Biol; 2001; 69():1-46. PubMed ID: 11550792
[TBL] [Abstract][Full Text] [Related]
2. LNA derivatives of a kissing aptamer targeted to the trans-activating responsive RNA element of HIV-1.
Lebars I; Richard T; Di Primo C; Toulmé JJ
Blood Cells Mol Dis; 2007; 38(3):204-9. PubMed ID: 17300966
[TBL] [Abstract][Full Text] [Related]
3. In vitro selection identifies key determinants for loop-loop interactions: RNA aptamers selective for the TAR RNA element of HIV-1.
Ducongé F; Toulmé JJ
RNA; 1999 Dec; 5(12):1605-14. PubMed ID: 10606271
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of inhibition of in vitro dimerization of HIV type I RNA by sense and antisense oligonucleotides.
Skripkin E; Paillart JC; Marquet R; Blumenfeld M; Ehresmann B; Ehresmann C
J Biol Chem; 1996 Nov; 271(46):28812-7. PubMed ID: 8910525
[TBL] [Abstract][Full Text] [Related]
5. Regulating eukaryotic gene expression with aptamers.
Toulmé JJ; Di Primo C; Boucard D
FEBS Lett; 2004 Jun; 567(1):55-62. PubMed ID: 15165893
[TBL] [Abstract][Full Text] [Related]
6. RNA and N3'-->P5' kissing aptamers targeted to the trans-activation responsive (TAR) RNA of the human immunodeficiency virus-1.
Darfeuille F; Cazenave C; Gryaznov S; Ducongé F; Di Primo C; Toulmé JJ
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):441-9. PubMed ID: 11563059
[TBL] [Abstract][Full Text] [Related]
7. Rational and combinatorial strategies for designing oligonucleotides targeted to RNA structures.
Toulmé JJ; Le Tinévez R; Boiziau C; Dausse E
Nucleic Acids Symp Ser; 1997; (36):39-41. PubMed ID: 9478200
[TBL] [Abstract][Full Text] [Related]
8. Modulating viral gene expression by aptamers to RNA structures.
Toulmé JJ; Darfeuille F; Kolb G; Chabas S; Staedel C
Biol Cell; 2003; 95(3-4):229-38. PubMed ID: 12867086
[TBL] [Abstract][Full Text] [Related]
9. Aptamers targeted to an RNA hairpin show improved specificity compared to that of complementary oligonucleotides.
Darfeuille F; Reigadas S; Hansen JB; Orum H; Di Primo C; Toulmé JJ
Biochemistry; 2006 Oct; 45(39):12076-82. PubMed ID: 17002307
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibition of in vitro reverse transcription using antisense oligonucleotides targeted to the TAR regions of HIV-1 and HIV-2.
Boulme F; Perälä-Heape M; Sarih-Cottin L; Litvak S
Biochim Biophys Acta; 1997 Apr; 1351(3):249-55. PubMed ID: 9130587
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of HIV-1 reverse transcription by triple-helix forming oligonucleotides with viral RNA.
Volkmann S; Jendis J; Frauendorf A; Moelling K
Nucleic Acids Res; 1995 Apr; 23(7):1204-12. PubMed ID: 7537875
[TBL] [Abstract][Full Text] [Related]
12. LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1.
Darfeuille F; Hansen JB; Orum H; Di Primo C; Toulmé JJ
Nucleic Acids Res; 2004; 32(10):3101-7. PubMed ID: 15181175
[TBL] [Abstract][Full Text] [Related]
13. DNA aptamers selected against the HIV-1 trans-activation-responsive RNA element form RNA-DNA kissing complexes.
Boiziau C; Dausse E; Yurchenko L; Toulmé JJ
J Biol Chem; 1999 Apr; 274(18):12730-7. PubMed ID: 10212256
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.
Arzumanov A; Walsh AP; Rajwanshi VK; Kumar R; Wengel J; Gait MJ
Biochemistry; 2001 Dec; 40(48):14645-54. PubMed ID: 11724578
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element.
Vickers T; Baker BF; Cook PD; Zounes M; Buckheit RW; Germany J; Ecker DJ
Nucleic Acids Res; 1991 Jun; 19(12):3359-68. PubMed ID: 2062653
[TBL] [Abstract][Full Text] [Related]
16. In vitro effect of antisense oligonucleotides on human immunodeficiency virus type 1 reverse transcription.
Bordier B; Hélène C; Barr PJ; Litvak S; Sarih-Cottin L
Nucleic Acids Res; 1992 Nov; 20(22):5999-6006. PubMed ID: 1281317
[TBL] [Abstract][Full Text] [Related]
17. A structure-activity study of the inhibition of HIV-1 Tat-dependent trans-activation by mixmer 2'-O-methyl oligoribonucleotides containing locked nucleic acid (LNA), alpha-L-LNA, or 2'-thio-LNA residues.
Arzumanov A; Stetsenko DA; Malakhov AD; Reichelt S; Sørensen MD; Babu BR; Wengel J; Gait MJ
Oligonucleotides; 2003; 13(6):435-53. PubMed ID: 15025911
[TBL] [Abstract][Full Text] [Related]
18. Targeting RNA structures by antisense oligonucleotides.
Toulmé JJ; Tinévez RL; Brossalina E
Biochimie; 1996; 78(7):663-73. PubMed ID: 8955909
[TBL] [Abstract][Full Text] [Related]
19. Bimodal loop-loop interactions increase the affinity of RNA aptamers for HIV-1 RNA structures.
Boucard D; Toulmé JJ; Di Primo C
Biochemistry; 2006 Feb; 45(5):1518-24. PubMed ID: 16445294
[TBL] [Abstract][Full Text] [Related]
20. NMR structure of a kissing complex formed between the TAR RNA element of HIV-1 and a LNA-modified aptamer.
Lebars I; Richard T; Di Primo C; Toulmé JJ
Nucleic Acids Res; 2007; 35(18):6103-14. PubMed ID: 17768146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
